Defibrillators Market Growth Analysis: USD 21.54 Billion Forecast by 2028

Posted by Mark Methu Aug 18

Filed in Other 17 views

Market Overview and Growth Outlook

The defibrillators market is forecast to reach USD 21.54 billion by 2028 from an estimated USD 12.65 billion in 2022. This represents a CAGR of 9.18% over the 2023-2028 forecast period. The market's growth is closely associated with the need for rapid cardiac intervention and wider deployment of defibrillation technology across healthcare and public environments.

The defibrillators market is expected to grow at a CAGR of 9.18% during 2023-2028. The source identifies cardiovascular disease, cardiac arrest, arrhythmias, technological advancement, early-defibrillation awareness, government action, and healthcare infrastructure as key factors behind the market's development.

The growth profile also differs across segments. Implantable cardioverter defibrillators accounted for more than 65% of the market in 2022, while external defibrillators recorded a CAGR of nearly 9.2%. Within end users, hospitals held more than 75%, while public access markets recorded a CAGR of nearly 9.5%.

These differences make defibrillators market growth a multi-dimensional issue. Market expansion is not limited to one technology or customer group; it includes implantable systems, external devices, hospital demand, emergency settings, public access locations, and home care facilities.

Request a free sample report: https://www.stratviewresearch.com/Request-Sample/defibrillators-market#form

Market Segmentation Analysis

By Type, the defibrillators market is segmented into Implantable Cardioverter Defibrillators and External Defibrillators. ICDs held more than 65% market share in 2022, while external defibrillators recorded the fastest CAGR of nearly 9.2% during the forecast period. The source attributes the ICD segment's position to technologically enhanced devices, extended life spans, increasing implant procedures, and adoption of CRT-D and S-ICD systems.

By End-User Type, the market is segmented into Hospitals, Clinics, and Cardiac Centers; Prehospital Care Settings; Public Access Markets; Alternate Care Facilities; and Home Care Facilities. Hospitals, clinics, and cardiac centers held the largest share in 2022, while hospitals represented more than 75%. Public access markets recorded a CAGR of nearly 9.5%.

Regional Market Insights

North America held more than 30% of the market in 2022 and is expected to continue its dominance throughout the forecast period. Increasing geriatric population, growing incidents of cardiac diseases, and technological advancements are identified as the principal factors supporting regional growth.

Asia-Pacific and Europe are expected to offer substantial growth opportunities. The source identifies both regions as important growth areas, while North America remains the region expected to maintain market leadership during the forecast period.

Emerging Trends Shaping the Defibrillators Market

The industry direction is increasingly connected with technological enhancement. The source points to devices with extended life spans and the growing adoption of CRT-D and S-ICD systems as factors contributing to the position of implantable cardioverter defibrillators.

Public access is another visible direction within the market. The source highlights increased availability in airports, retail centers, sporting venues, and transit hubs, while government mandates in several nations support installation in public spaces, schools, and workplaces.

Key Growth Drivers of the Market

  • Cardiovascular disease: Cardiac arrest and arrhythmias create direct demand because defibrillators are used to restore normal heart rhythms during critical events.
  • Technology advancement: Device development supports market growth and has improved accessibility for non-medical professionals using automated external defibrillators.
  • Early intervention: Awareness campaigns and training initiatives strengthen understanding of prompt defibrillation following cardiac arrest.
  • Government support: Laws mandating installations in several nations expand demand across schools, workplaces, and public locations.
  • Healthcare development: Expanding healthcare infrastructure increases access to medical treatment and supports demand in hospitals, clinics, and ambulatory care centers.

Competitive Landscape

Top Companies in the Market

  • Biotronik
  • Boston Scientific
  • CU Medical Systems, Inc.
  • Koninklijke Philips N.V.
  • Mediana
  • Medtronic plc
  • Metsis Medikal
  • Microport
  • Mindray Medical
  • Nihon Kohden

Conclusion and Strategic Outlook

The defibrillators market combines strong overall growth with varied segment performance. A 9.18% CAGR between 2023 and 2028 supports a forecast increase from USD 12.65 billion in 2022 to USD 21.54 billion in 2028. Technology development and wider emergency accessibility remain central to the stated market trajectory.

The competitive landscape includes ten key companies identified by Stratview Research. With North America maintaining leadership and Asia-Pacific and Europe offering substantial opportunities, market development remains connected to healthcare access, device technology, awareness, and public deployment.

FAQs – Defibrillators Market

1. What is the forecast size of the defibrillators market?

The market was estimated at USD 12.65 billion in 2022 and is expected to reach USD 21.54 billion in 2028.

2. What is the expected growth rate?

The defibrillators market is projected to grow at a CAGR of 9.18% during 2023-2028.

3. What are the main growth drivers?

The source identifies cardiovascular diseases, technology development, awareness initiatives, government measures, healthcare infrastructure, and wider public availability as major drivers.

4. Where is demand strongest?

North America was the largest regional market in 2022 and is expected to retain its dominance. Asia-Pacific and Europe are expected to provide substantial growth opportunities.

5. What should industry participants monitor?

Industry participants should monitor technology development, segment-level growth, public accessibility, healthcare infrastructure, and competitive dynamics. These areas are included in the source's market assessment.

click to rate